Skip to main content
Top
Published in: Annals of Surgical Oncology 12/2021

01-11-2021 | Sarcoma | Sarcoma

Cumulative Burden of Postoperative Complications in Patients Undergoing Surgery for Primary Retroperitoneal Sarcoma

Authors: Fabio Tirotta, MD, Alessandro Parente, MD, James Hodson, BSc, Anant Desai, FRCS, MD, L. Max Almond, FRCS, MD, Samuel J. Ford, FRCS, PhD

Published in: Annals of Surgical Oncology | Issue 12/2021

Login to get access

Abstract

Background

Correlations between postoperative complications and oncological outcomes have been reported in several malignancies, but their impact in retroperitoneal sarcoma (RPS) is unclear. Our study aimed to evaluate the association between postoperative complications and prognosis in patients with RPS.

Methods

Patients undergoing surgery for primary RPS from 2008 to 2019 at a sarcoma center were evaluated. The cumulative burden of postoperative complications was quantified using the Comprehensive Complication Index (CCI), and associations with local recurrence (LR), distant metastases (DM) and overall survival (OS) were assessed.

Results

Data were available for 191 patients, of whom 160 (82.9%) developed at least one postoperative complication, with a median CCI of 20.9 (interquartile range 8.7–33.5). After postoperative deaths were excluded (n = 3, 1.6%), the remaining patients were divided into those with a CCI of 0–20.9 (n = 97) and > 20.9 (n = 91). Patients with a CCI >20.9 had significantly shorter OS than those with a CCI of 0–20.9 (43.3% vs. 69.5% at 5 years; p = 0.005), and this difference remained significant after multivariable adjustment for patient- and treatment-related factors [hazard ratio (HR) 2.31, 95% confidence interval (CI) 1.30–4.09; p = 0.004]. However, CCI > 20.9 was not found to be a significant independent predictor of either LR (HR 1.30, 95% CI 0.76–2.23; p = 0.333) or DM (HR 1.08, 95% CI 0.61–1.93; p = 0.786).

Conclusion

Increasing complication burden, as quantified by the CCI, is a significant independent predictor of OS; however, there is no evidence of a significant association with either LR or DM, which may be more related to tumor biological factors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2008;27:24–30.CrossRef Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2008;27:24–30.CrossRef
2.
go back to reference Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–7.CrossRef Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–7.CrossRef
3.
go back to reference Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate- grade soft tissue sarcomas. Ann Oncol. 2011;23:1067–73.CrossRef Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate- grade soft tissue sarcomas. Ann Oncol. 2011;23:1067–73.CrossRef
4.
go back to reference Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centres is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.CrossRef Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centres is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.CrossRef
5.
go back to reference MacNeill AJ, Gronchi A, Miceli R, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma. Ann Surg. 2018;267:959–64.CrossRef MacNeill AJ, Gronchi A, Miceli R, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma. Ann Surg. 2018;267:959–64.CrossRef
6.
go back to reference Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258:1–7.CrossRef Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258:1–7.CrossRef
7.
go back to reference Slankamenac K, Nederlof N, Pessaux P, et al. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014;260:757–62.CrossRef Slankamenac K, Nederlof N, Pessaux P, et al. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014;260:757–62.CrossRef
8.
go back to reference Yamashita S, Sheth RA, Niekamp AS, et al. Comprehensive complication index predicts cancer-specific survival after resection of colorectal metastases independent of RAS mutational status. Ann Surg. 2017;266:1045–54.CrossRef Yamashita S, Sheth RA, Niekamp AS, et al. Comprehensive complication index predicts cancer-specific survival after resection of colorectal metastases independent of RAS mutational status. Ann Surg. 2017;266:1045–54.CrossRef
10.
go back to reference Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.CrossRef Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.CrossRef
11.
go back to reference Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRef Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRef
12.
go back to reference Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986;58:306–9.CrossRef Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986;58:306–9.CrossRef
13.
go back to reference Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef
14.
go back to reference Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef
16.
go back to reference Slaman AE, Lagarde SM, Gisbertz SS, et al. A quantified scoring system for postoperative complication severity compared to the Clavien-Dindo classification. Dig Surg. 2015;32:361–6.CrossRef Slaman AE, Lagarde SM, Gisbertz SS, et al. A quantified scoring system for postoperative complication severity compared to the Clavien-Dindo classification. Dig Surg. 2015;32:361–6.CrossRef
17.
go back to reference Nederlof N, Slaman AE, van Hagen P, et al. Using the comprehensive complication index to assess the impact of neoadjuvant chemoradiotherapy on complication severity after esophagectomy for cancer. Ann Surg Oncol. 2016;23:3964–71.CrossRef Nederlof N, Slaman AE, van Hagen P, et al. Using the comprehensive complication index to assess the impact of neoadjuvant chemoradiotherapy on complication severity after esophagectomy for cancer. Ann Surg Oncol. 2016;23:3964–71.CrossRef
18.
go back to reference Marsman EM, de Rooij T, van Eijck CH, et al. Pancreatoduodenectomy with colon resection for cancer: a nationwide retrospective analysis. Surgery. 2016;160:145–52.CrossRef Marsman EM, de Rooij T, van Eijck CH, et al. Pancreatoduodenectomy with colon resection for cancer: a nationwide retrospective analysis. Surgery. 2016;160:145–52.CrossRef
19.
go back to reference Dumitra S, O’Leary M, Raoof M, et al. The Comprehensive complication index: a new measure of the burden of complications after hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25:688–93.CrossRef Dumitra S, O’Leary M, Raoof M, et al. The Comprehensive complication index: a new measure of the burden of complications after hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25:688–93.CrossRef
20.
go back to reference Kim T, Suh Y, Huh Y, et al. The comprehensive complication index (CCI) is a more sensitive complication index than the conventional Clavien-Dindo classification in radical gastric cancer surgery. Gastric Cancer. 2018;21:171–81.CrossRef Kim T, Suh Y, Huh Y, et al. The comprehensive complication index (CCI) is a more sensitive complication index than the conventional Clavien-Dindo classification in radical gastric cancer surgery. Gastric Cancer. 2018;21:171–81.CrossRef
21.
go back to reference Vetterlein MW, Klemm J, Gild P, et al. Improving estimates of perioperative morbidity after radical cystectomy using the european association of urology quality criteria for standardized reporting and introducing the comprehensive complication index. Eur Urol. 2020;77:55–65.CrossRef Vetterlein MW, Klemm J, Gild P, et al. Improving estimates of perioperative morbidity after radical cystectomy using the european association of urology quality criteria for standardized reporting and introducing the comprehensive complication index. Eur Urol. 2020;77:55–65.CrossRef
22.
go back to reference Sánchez-Velázquez P, Muller X, Malleo G, et al. Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons. Ann Surg. 2019;270:211–8.CrossRef Sánchez-Velázquez P, Muller X, Malleo G, et al. Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons. Ann Surg. 2019;270:211–8.CrossRef
23.
go back to reference Saeki H, Tsutsumi S, Tajiri H, et al. Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg. 2017;265:527–33.CrossRef Saeki H, Tsutsumi S, Tajiri H, et al. Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg. 2017;265:527–33.CrossRef
24.
go back to reference Tokunaga M, Tanizawa Y, Bando E, et al. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol. 2013;20:1575–83.CrossRef Tokunaga M, Tanizawa Y, Bando E, et al. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol. 2013;20:1575–83.CrossRef
25.
go back to reference Artinyan A, Orcutt ST, Anaya DA, et al. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg. 2015;261:497–505.CrossRef Artinyan A, Orcutt ST, Anaya DA, et al. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg. 2015;261:497–505.CrossRef
26.
go back to reference Yang T, Liu K, Liu CF, et al. Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma. Br J Surg. 2019;106:1228–2126.CrossRef Yang T, Liu K, Liu CF, et al. Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma. Br J Surg. 2019;106:1228–2126.CrossRef
27.
go back to reference Laurent C, Sa Cunha A, Couderc P, et al. Influence of postoperative morbidity on long- term survival following liver resection for colorectal metastases. Br J Surg. 2003;90:1131–6.CrossRef Laurent C, Sa Cunha A, Couderc P, et al. Influence of postoperative morbidity on long- term survival following liver resection for colorectal metastases. Br J Surg. 2003;90:1131–6.CrossRef
28.
go back to reference Krarup PM, Nordholm-Carstensen A, Jorgensen LN, et al. Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study. Ann Surg. 2014;259:930–8.CrossRef Krarup PM, Nordholm-Carstensen A, Jorgensen LN, et al. Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study. Ann Surg. 2014;259:930–8.CrossRef
29.
go back to reference Kamphues C, Bova R, Schricke D, et al. Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. Ann Surg Oncol. 2012;19:856–63.CrossRef Kamphues C, Bova R, Schricke D, et al. Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. Ann Surg Oncol. 2012;19:856–63.CrossRef
30.
go back to reference Lyu HG, Saadat LV, Bertagnolli MM, et al. Enhanced recovery after surgery pathway in patients with soft tissue sarcoma. Br J Surg. 2020;107:1667–72.CrossRef Lyu HG, Saadat LV, Bertagnolli MM, et al. Enhanced recovery after surgery pathway in patients with soft tissue sarcoma. Br J Surg. 2020;107:1667–72.CrossRef
Metadata
Title
Cumulative Burden of Postoperative Complications in Patients Undergoing Surgery for Primary Retroperitoneal Sarcoma
Authors
Fabio Tirotta, MD
Alessandro Parente, MD
James Hodson, BSc
Anant Desai, FRCS, MD
L. Max Almond, FRCS, MD
Samuel J. Ford, FRCS, PhD
Publication date
01-11-2021
Publisher
Springer International Publishing
Keyword
Sarcoma
Published in
Annals of Surgical Oncology / Issue 12/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10059-1

Other articles of this Issue 12/2021

Annals of Surgical Oncology 12/2021 Go to the issue